Lilly's rheumatoid arthritis pill rejected by regulators
Friday, April 14, 2017 - 10:31
in Health & Medicine
Eli Lilly says U.S. regulators have rejected its much-anticipated pill for the immune disorder rheumatoid arthritis, the drugmaker's second drug development setback since November....